DecisionPoint Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15K Buy
23
+1
+5% +$594 ﹤0.01% 216
2026
Q2
$11.3K Sell
22
-5
-19% -$2.4K ﹤0.01% 193
2026
Q1
$13.3K Hold
27
– – ﹤0.01% 167
2025
Q4
$15.6K Buy
27
+20
+286% +$11.3K ﹤0.01% 160
2025
Q3
$3.72K Hold
7
– – ﹤0.01% 193
2025
Q2
$2.95K Buy
+7
New +$2.93K ﹤0.01% 206
2023
Q2
– Sell
-20
Closed -$11.5K – 215
2023
Q1
$11.5K Buy
+20
New +$11.3K 0.01% 107

Other funds holding TMO

DecisionPoint Financial's TMO Position: Q3 2026 in Review

DecisionPoint Financial increased its Thermo Fisher Scientific (TMO) stake by 4.5% in Q3 2026, buying an estimated $594 and bringing the position to 23 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

DecisionPoint Financial first reported a position in TMO in Q1 2023 and has held it in 7 quarters since. The position peaked at $15.6K in Q4 2025. 1,018 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • DecisionPoint Financial held 23 shares of Thermo Fisher Scientific worth $15K as of Q3 2026.
  • DecisionPoint Financial bought 1 Thermo Fisher Scientific share in Q3 2026, an estimated $594.
  • Thermo Fisher Scientific made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #216 holding.
  • DecisionPoint Financial first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 7 quarters since.
  • DecisionPoint Financial's Thermo Fisher Scientific position peaked at $15.6K in Q4 2025.
  • 1,018 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.